Asthma Therapy May Differ for Women
Pathology and Laboratory Medicine postdoctoral scholar Lauren Solomon has shown how estrogen is reducing the efficacy of steroid-based treatment, which may be contributing to the severity of asthma in women.
For women depending on steroids to treat severe asthma, their body’s estrogen may be reducing the treatment from working effectively and contributing to severity of symptoms, according to a recent Western study.
“We had assumed estrogen would just affect how well the steroid works – it didn’t. It makes them different and more aggressive,” said Lauren Solomon, a postdoctoral scholar working with Pathology and Laboratory Medicine professor Lisa Cameron. “The steroids are still suppressing inflammation. So the symptoms are being treated. But it’s not treating the actual white blood cells causing it. So when they get exposed to another allergen, the asthma comes again – and it’s worse.”
Currently affecting about three million Canadians, Asthma is a chronic inflammatory disease of the airway. While sufferers’ airways are inflamed, to some degree, all the time, the more inflamed the airway the more difficulty they have in breathing.
When Solomon began working with Cameron, they noticed women with severe asthma differed from their male counterparts. Determined through blood samples, women had more of a specific T cell – a type of white blood cell of key importance to the immune system – than the men, making Solomon wonder if it was related to “those pesky sex hormones.”
She began working with cell culture models from blood donors, adding estrogen and steroids.
“We can treat the cells for 24 hours with estrogen and steroids and the next day, when we activate them, they produce way more mediators, meaning the next time they are exposed to an antigen, inflammation could be worse,” said Solomon.
“In patients, steroids are still suppressing inflammation, but not completely, which could lead to persistent symptoms. Also, steroids are not eliminating the actual white blood cells causing the inflammation,” she continued.
This data could suggest women with asthma may need more steroid or newer therapies to control their asthma.
Solomon is continuing her work by exploring specific RNA sequencing targets where she can enumerate the cells, allowing her to determine whose medication is not working and making them better candidates for newer therapies or medications.
“If we can get this information out there, if we can influence prescribing habits, there are alternative drugs that are already approved,” she said. “We can now say if it’s a woman going through menopause taking hormone replacement therapy, maybe check her estrogen levels.”
